Experts Welcome Generic Semaglutide, Urge Caution on Reliance

Canadian medical experts and patient advocates are calling Health Canada's authorization of generic semaglutide a major equity win, while warning that broader access should not eclipse public-health work on the conditions that drive demand for the drug [Source: cp24.com/news/canada/2026/04/30/how-generic-versions-of-ozempic-could-shape-canada/].

What Health Canada approved

Health Canada authorized the first generic semaglutide injection on April 28, 2026, a product filed by Dr. Reddy's Laboratories and referenced to brand-name Ozempic [Source: canada.ca/en/health-canada/news/2026/04/canada-becomes-the-first-g7-country-to-approve-a-generic-version-of-semaglutide.html]. The regulator confirmed Canada is the first G7 country to authorize a generic semaglutide [Source: canada.ca/en/health-canada/news/2026/04/canada-becomes-the-first-g7-country-to-approve-a-generic-version-of-semaglutide.html]. A second generic, filed by Toronto-headquartered Apotex, was authorized days later, with eight other submissions previously listed as under review [Source: cbc.ca/news/health/ozempic-semaglutide-generic-version-canada-9.7184915].

'Really good news' for access

Dr. Kaberi Dasgupta, a professor of medicine at McGill University, told CP24 the approval increases equity and called semaglutides "incredible tools" for patients managing excess weight and related conditions [Source: cp24.com/news/canada/2026/04/30/how-generic-versions-of-ozempic-could-shape-canada/]. Ian Patton, director of advocacy and public engagement for Obesity Canada, also welcomed the news, saying patients "haven't had a lot of options that are effective, evidence-based treatments for a long time" [Source: cp24.com/news/canada/2026/04/30/how-generic-versions-of-ozempic-could-shape-canada/].

Patton, who described his own care pathway including bariatric surgery and ongoing semaglutide use, said the medication had been "absolutely life changing" for him personally [Source: ctvnews.ca/health/article/how-generic-versions-of-ozempic-could-shape-canada/].

Experts caution against over-reliance

Dasgupta cautioned that wider availability could shift focus away from environmental and lifestyle drivers of chronic disease. "The negative side is that it might become a bit too easy to not try to make our environments healthier," she said [Source: cp24.com/news/canada/2026/04/30/how-generic-versions-of-ozempic-could-shape-canada/]. She suggested governments should fund surveillance programs for people with pre-diabetes and improve access to dieticians and exercise counselling [Source: cp24.com/news/canada/2026/04/30/how-generic-versions-of-ozempic-could-shape-canada/].

Dr. Hertzel Gerstein, a diabetes doctor and researcher in Hamilton and director of the Population Health Research Institute jointly run by McMaster University and Hamilton Health Sciences, told CBC News these are "powerful drugs" that should not be treated like supplements or over-the-counter products [Source: cbc.ca/news/health/ozempic-semaglutide-generic-version-canada-9.7184915].

What it could mean for prices

CBC reported that, depending on dose, Canadians without coverage have been paying about $300 to $400 per month, sometimes more, for brand-name semaglutide [Source: cbc.ca/news/health/ozempic-semaglutide-generic-version-canada-9.7184915]. Current pharmacy listings on GLP1Prices.ca place Ozempic between $222 and $663 CAD across Canadian pharmacies, broadly consistent with that range.

Under the pan-Canadian Pharmaceutical Alliance pricing structure cited by CBC, the first generic semaglutide could be priced at 75 to 85 per cent of the brand, dropping to 50 per cent when a second product enters the market and to about 35 per cent once three or more generics are available [Source: cbc.ca/news/health/ozempic-semaglutide-generic-version-canada-9.7184915].

Timing and rollout

Catherine Thomas, Apotex's vice president of global communications, told CBC News the company's generic should be available to Canadians within weeks and that work was underway with private insurers on coverage [Source: cbc.ca/news/health/ozempic-semaglutide-generic-version-canada-9.7184915]. Patients tracking the wider pipeline can monitor our generic semaglutide tracker and review payer status through our insurance coverage checker; further background on related products including Wegovy, Rybelsus, Mounjaro and Zepbound is available in our FAQ.

This article is for informational purposes only and does not constitute medical advice.